Articles tagged "Risk factors"

2022 American Transplant Congress
Sarcopenia and Testosterone Deficiency with Chronic Liver Disease; Post-Liver Transplant Utility of Short Term Testosterone Replacement Therapy
A. Jain¹, D. Haussner²
¹Penn State Health Milton S. Hershey Medical Center, Hershey, PA, ²Presbyterian, New York, NY
*Purpose: Chronic liver disease is often associated with testosterone deficiency. However, testosterone therapy does not improve survival. So far, after a successful liver transplant (LTx),…
2022 American Transplant Congress
Tracheostomy After Liver Transplantation: Utility and Impact
D. Noguchi, V. M. Nguyen, C. J. Rosenthal, V. G. Agopian, D. G. Farmer, F. M. Kaldas
Liver and Pancreas Transplant Center, UCLA, Los Angeles, CA
*Purpose: High acuity Liver transplant (LT) patients have an increased risk of postoperative respiratory failure requiring tracheostomy (TS). The use of TS in ventilator-dependent patients…
2022 American Transplant Congress
BMI Trajectory and Attributable Risk of New Onset Hypertension Among Obese Living Kidney Donors
R. D. Reed¹, M. C. McLeod¹, P. A. MacLennan¹, V. Kumar¹, S. E. Brooks¹, A. G. Maynor¹, L. A. Stanford¹, G. A. Baker¹, C. A. Schinstock², J. R. Silkensen³, G. R. Roll⁴, D. L. Segev⁵, B. J. Orandi¹, C. E. Lewis⁶, J. E. Locke¹
¹Surgery, University of Alabama at Birmingham, Birmingham, AL, ²Nephrology and Hypertension, Mayo Clinic, Rochester, MN, ³Medicine, Hennepin County Medical Center, Minneapolis, MN, ⁴Surgery, University of California San Francisco, San Francisco, CA, ⁵Surgery, Johns Hopkins University, Baltimore, MD, ⁶Epidemiology, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Obesity increases hypertension risk in general and living kidney donor populations. Risk attributable to donation in the context of obesity and whether that risk…
2022 American Transplant Congress
Risk Factors for Extubation Failure Post- Lung Transplantation
A. J. Trindade¹, W. D. Gannon¹, A. G. Dragnich¹, G. Dahlberg¹, C. T. Demarest², E. S. Lambright², K. A. McPherson¹, S. G. Norfolk¹, C. M. Shaver¹, I. M. Robbins¹, M. Bacchetta²
¹Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, TN, ²Thoracic Surgery, Vanderbilt University Medical Center, Nashville, TN
*Purpose: Extubation delays following lung transplantation can result in delirium, deconditioning, infections, and increased hospital length of stay. Risk stratifying patients for extubation failure may…
2022 American Transplant Congress
In Kidney Recipients from the Same Deceased Donor, Discordance in Delayed Graft Function is Associated with Poor Outcomes
E. A. Yousif, B. Muth, V. Manchala, J. Turk, J. Blazel, M. Bloom, N. Garg, F. Aziz, M. Mohamed, A. Djamali, D. Mandelbrot, S. Parajuli
University of Wisconsin, Madison, WI
*Purpose: Delayed graft function (DGF) is a common complication among deceased donor kidney transplant recipients (DDKTs) and is associated with worse outcomes. The effect on…
2022 American Transplant Congress
Post-Kidney Donation Pregnancy Complications and Long-Term Outcomes
E. F. Palzer¹, E. S. Helgeson¹, M. Evans², D. Vock¹, A. Matas³
¹Biostatistics, University of Minnesota, Minneapolis, MN, ²Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, ³Surgery, University of Minnesota Medical School, Minneapolis, MN
*Purpose: In the general population, pregnancy complications are associated with long-term maternal risk. Kidney donors with postdonation pregnancies have increased risk of gestational HTN and…
2022 American Transplant Congress
Recurrence of Focal Segmental Glomerulosclerosis After Kidney Transplantation According to Pre-Transplant Treatment
H. Kwon, S. Shin, Y. Kim
Department of general surgery, Asan Medical Center, Seoul, Korea, Republic of
*Purpose: Focal segmental glomerulosclerosis (FSGS) recurrence after kidney transplantation (KT) is a significant risk factor of graft failure. The recurrence of FSGS develops in 30%-60%…
2022 American Transplant Congress
Risk Factors for Micafungin Non-Susceptible Invasive Candidiasis in Solid Organ Transplant Recipients
U. Dhal, J. Morillas-Rodriguez, K. D. Brizendine
Cleveland Clinic, Cleveland, OH
*Purpose: Determine risk factors associated with micafungin non-susceptible invasive candidiasis (IC) in solid organ transplant (SOT) recipients*Methods: We conducted a retrospective study of SOT patients…
2022 American Transplant Congress
Liver Transplantation in Patients with Portal Vein Thrombosis: Implications and Outcomes
D. Noguchi, C. J. Rosenthal, M. Ha, V. G. Agopian, D. G. Farmer, F. M. Kaldas
Liver and Pancreas Transplant Center, UCLA, Los Angeles, CA
*Purpose: Preoperative bland portal vein thrombosis (PVT) is common in Liver transplant (LT) candidates and has been suspected to negatively impact post-LT outcomes, however studies…
2022 American Transplant Congress
Baseline Predictors of Antimicrobial Utilization in Solid Organ Transplant Recipients
M. Govil¹, D. Xie¹, L. S. Hynan², S. L. Spitznogle¹, M. L. Monogue¹, J. Sanders¹, E. Bae¹, J. B. Cutrell¹, R. M. La Hoz¹
¹University of Texas Southwestern Medical Center, Dallas, TX, ²University of Texas at Southwestern, Dallas, TX
*Purpose: Antimicrobial use (AU) is a major driver of antimicrobial resistance but is understudied in solid organ transplant (SOT) recipients. Our study sought to quantify…